TrialThe Lancet. Infectious diseases2014

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.

Glenda E Gray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.